Local view for "https://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/Evidence/846"

Predicate	Value (sorted: none)
rdf:type	?:Evidence
rdf:type	?:Item
rdfs:label	"evidence_1562"
?:Evidence_type	?:Non_traceable_Drug_Label_Statement
?:Evidence_enzyme_system	""
dc:creator	"boycer"
dc:date	"05/05/2009 17:51:26"
?:content	"12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range. Steady-state plasma concentrations are typically achieved after 3 days of dosing. Elimination of duloxetine is mainly through hepatic metabolism involving two P450 isozymes, CYP1A2 and CYP2D6."
rdfs:seeAlso	?:2f7d4d67-10c1-4bf4-a7f2-c185fbad64ba

All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines/dikb.ttl

The resource appears as object in one triple:

{ duloxetine_substrate_of_cyp1a2, <http://purl.org/swan/1.2/swan-commons#citesAsSupportingEvidence>, evidence_1562 }

Context graph